IHME, University of Washington, USA.
Vaccine. 2019 Aug 7;37(34):4784-4786. doi: 10.1016/j.vaccine.2019.01.031. Epub 2019 Jan 31.
The mortality and morbidity burden estimation of diarrheal diseases (DD), and Shigella and Enterotoxigenic E. Coli (ETEC) varies among different studies and by the models used for producing these estimates. Understanding the real burden of these important pathogens will guide public health and policy makers to prioritize resources for accelerating interventions against these enteric infections. In addition, long term effects, in the form of growth faltering, cognitive impairment and decreased school performance are important aspects of burden that has not been well captured. Efforts to incorporate these effects and refine their estimation, in the form of Disability Adjusted Life years (DALYs) are very important to inform the burden of diarrheal diseases and Shigella and ETEC specifically. The Institute for Health Metrics and Evaluation (IHME) at the University of Washington conducted a workshop at the VASE 2018 meeting to discuss IHME Global Burden of Diseases (GBD) modelling methods for diarrheal diseases, with a focus on ETEC and Shigella estimates in relation to other pathogens, including limitations, areas of improvements, and IHME plans for future GBD iterations.
腹泻病(DD)、志贺菌和肠产毒性大肠杆菌(ETEC)的死亡率和发病率负担估计在不同的研究和用于产生这些估计的模型中有所不同。了解这些重要病原体的真实负担将指导公共卫生和政策制定者优先为加速针对这些肠道感染的干预措施提供资源。此外,生长迟缓、认知障碍和学习成绩下降等长期影响是负担的重要方面,尚未得到很好的捕捉。努力纳入这些影响,并以残疾调整生命年(DALYs)的形式对其进行估算,对于了解腹泻病和志贺菌以及 ETEC 的具体负担非常重要。华盛顿大学健康计量与评估研究所(IHME)在 2018 年 VASE 会议上举办了一个研讨会,讨论 IHME 全球疾病负担(GBD)腹泻病建模方法,重点是 ETEC 和志贺菌与其他病原体的估计,包括局限性、改进领域以及 IHME 未来 GBD 迭代计划。